Liquidia Corporation
NASDAQ:LQDA
Overview | Financials
Company Name | Liquidia Corporation |
Symbol | LQDA |
Currency | USD |
Price | 10.83 |
Market Cap | 901,645,152 |
Dividend Yield | 0% |
52-week-range | 6.06 - 16.99 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Roger A. Jeffs Ph.D. |
Website | https://www.liquidia.com |
An error occurred while fetching data.
About Liquidia Corporation
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD